BPG is committed to discovery and dissemination of knowledge
Article Quality Tracking-Peer-Review
Publication Name
Article Title
Manuscript ID Reviewer Code
Year Published Author(s)
1
"This review examines a very interesting aspect of aGVHD in aHSCT patients: how changes in the intestinal flora initiate the disease. The decrease of the gut microbiome diversity or metabolic pathways are associated with aGVHD. These specific changes could serve not just as biomarker for diagnosis and prevention in patients receiving aHSCT, but can be the basis of new modulatory therapies of the gut microbiome for preventing aGVHD in this group of patients. " 
Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [DOI: 10.3748/wjg.v27.i45.7792]
2
"The use of miRNA profiles for distinguishing IBD subtypes is logical. It would have been interesting to know how this study resulted in more or new details than the following reports that should have been quoted: Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. BMC Immunol. 2015 Feb 10;16:5. doi: 10.1186/s12865-015-0069-0. Lin J, Zhang X, Zhao Z, Welker NC, Li Y, Liu Y, Bronner MP. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing. Microrna. 2016;5(3):222-229. " 
Quaglio AEV, Santaella FJ, Rodrigues MAM, Sassaki LY, Di Stasi LC. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers. World J Gastroenterol 2021; 27(45): 7801-7812 [DOI: 10.3748/wjg.v27.i45.7801]
3
"The results of this study may guarantee the conduction of double blind therapeutic clinical trials for the treatment of liver fibrosis in NAFLD patients. This drug is not approved in western countries yet. Primary end point may be improving of at least 1 stage of liver fibrosis without worsening of inflammation. Currently there is no pharmacological therapy for liver fibrosis in these patients. It is a very important issue since fibrosis is the main risk factor for mortality. Any effective anti-fibrotic therapy is welcomed." 
Xi Y, Xu PF. Therapeutic potentials of fasudil in liver fibrosis. World J Gastroenterol 2021; 27(45): 7859-7861 [DOI: 10.3748/wjg.v27.i45.7859]
4
"This manuscript was demonstrated meta-analysis for the use of HSCT in refractory cases till 2 years. Although the manuscript has well defined their criteria, it doesn't seem to fit the journal scope of WJBC." 
Muthu S, Jeyaraman M, Ranjan R, Jha SK. Remission is not maintained over 2 years with hematopoietic stem cell transplantation for rheumatoid arthritis: A systematic review with meta-analysis. World J Biol Chem 2021; 12(6): 114-130 [DOI: 10.4331/wjbc.v12.i6.114]
5
"This manuscript was demonstrated meta-analysis for the use of HSCT in refractory cases till 2 years. Although the manuscript has well defined their criteria, it doesn't seem to fit the journal scope of WJBC." 
Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6): 104-113 [DOI: 10.4331/wjbc.v12.i6.104]
6
"The current study was based on previous studies that the endocan is a target of miRNA 9-3p,and that the simultaneous assessment of the roles of both miRNA 9-3p and inflammatory role of endocan have not been evaluated in HCC. The work explored the diagnostic value of circulating levels of miRNA 9-3p and endocan in HCV-related HCC patients and correlated them with clinicopathological parameters. The authors concluded that the circulating miRNA 9-3p and endocan can be used as novel biomarkers for the early diagnosis of HCV-related HCC. Overall, the current study was interesting and well conducted regarding the ethics, methods, interpretation and language. The findings of this study warrant additional investigation in prospective trials with larger cohorts and longer follow-up for confirming the results and validating the potential clinical use of these markers in early HCC detection. Below are my comments regarding some of the caveats or drawbacks in the current study which I think could be helpful for the improvement of future study: 1.Sample size is small, with only 4 early HCC cases with BCLC stage A, and it would be better the chronic liver disease be categorized as cirrhosis, chronic hepatitis, and other causes of chronic liver disease like alcoholism. 2. In addition to figures, it would be better use tables but not text description to present the diagnostic value of miRNA 9-3p and endocan. 3.Regarding the statistical analysis, AUC value is usually accompanied with 95% CI. 4.How is the diagnostic performance of the combined miRNA 9-3p and endocan? 5. The discussion could be more concise and logical. " 
Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [DOI: 10.4254/wjh.v13.i11.1753]
7
"Article is informative however surgical method description with operative images would be more informative." 
Scroggie DL, Mavroeidis VK. Surgical ampullectomy: A comprehensive review. World J Gastrointest Surg 2021; 13(11): 1338-1350 [DOI: 10.4240/wjgs.v13.i11.1338]
8
"Spasmolytic polypeptide-expressing metaplasia (SPEM) is a potential preneoplastic lesion. Chen WQ tried to elucidate the microRNA (miR)-7-mediated preventive and inhibitive effects of Yiwei Xiaoyu granules (YWXY) in SPEM lesions, and found that miR-7 downregulation is an early event in SPEM through regulation of TFF2 in human gastric mucosa. YWXY is able to inhibit the cell proliferation and restore the expression of miR-7 by mediating TFF2 in the SPEM mouse model. It will be helpful for the clinicians in this area." 
Chen WQ, Tian FL, Zhang JW, Yang XJ, Li YP. Preventive and inhibitive effects of Yiwei Xiaoyu granules on the development and progression of spasmolytic polypeptide-expressing metaplasia lesions. World J Gastrointest Oncol 2021; 13(11): 1741-1754 [PMID: 34853647 DOI: 10.4251/wjgo.v13.i11.1741]
9
"This study by Sintusek P et al tried to review the progress in the liver tumors with underlying chronic liver disease, their epidemiology, pathogenesis, early recognition, and effective management. It is very interesting." 
Sintusek P, Phewplung T, Sanpavat A, Poovorawan Y. Liver tumors in children with chronic liver diseases. World J Gastrointest Oncol 2021; 13(11): 1680-1695 [PMID: 34853643 DOI: 10.4251/wjgo.v13.i11.1680]
10
"Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. Zamora-León SP tried to review the recent progress in the biomarkers of HCC. It will be helpful for the clinicians in this area." 
Zamora-León SP. Hepatocellular carcinoma biomarkers, an imminent need. World J Gastrointest Oncol 2021; 13(11): 1847-1849 [PMID: 34853655 DOI: 10.4251/wjgo.v13.i11.1847]
11
"Despite the use of current standard therapy, the prognosis of patients with unresectable hepatocellular carcinoma (HCC) is poor, with median survival times of 40 mo for intermediate HCC (Barcelona Clinic Liver Cancer [BCLC] stage B) and 6–8 mo for advanced HCC (BCLC stage C). This study by Ahmed F et al tried to conduct a systematic literature review to evaluate the evidence supporting the efficacy and safety of atezolizumab/bevacizumab as preferred first-line drug therapy over the conventional sorafenib or atezolizumab monotherapies. It is very interesting." 
Ahmed F, Onwumeh-Okwundu J, Yukselen Z, Endaya Coronel MK, Zaidi M, Guntipalli P, Garimella V, Gudapati S, Mezidor MD, Andrews K, Mouchli M, Shahini E. Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review. World J Gastrointest Oncol 2021; 13(11): 1813-1832 [PMID: 34853653 DOI: 10.4251/wjgo.v13.i11.1813]
12
"The long-term survival of patients with solitary hepatocellular carcinoma (HCC) following anatomical resection (AR) vs non-anatomical resection (NAR) is still controversial. In this study, authors tried to compare perioperative and long-term survival outcomes of AR and NAR for solitary HCC. The results showed that AR is superior to NAR in terms of long-term outcomes. It is very useful for the specialists in this area." 
Liu H, Hu FJ, Li H, Lan T, Wu H. Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis. World J Gastrointest Oncol 2021; 13(11): 1833-1846 [PMID: 34853654 DOI: 10.4251/wjgo.v13.i11.1833]
13
"Gastrointestinal tumors are among the most common cancer types, and early detection is paramount to improve their management. Cell-free DNA (cfDNA) liquid biopsy raises significant hopes for non-invasive early detection. The study tried to describe current applications of this technology for gastrointestinal cancer detection and screening, and found that cfDNA liquid biopsy seems capable of detecting gastrointestinal cancers at an early stage of development in a non-invasive and repeatable manner and screening simultaneously for multiple cancer types in a single blood sample. It is very useful." 
Uhe I, Hagen ME, Ris F, Meyer J, Toso C, Douissard J. Cell-free DNA liquid biopsy for early detection of gastrointestinal cancers: A systematic review. World J Gastrointest Oncol 2021; 13(11): 1799-1812 [PMID: 34853652 DOI: 10.4251/wjgo.v13.i11.1799]
14
"The incidence of colorectal cancer (CRC) is increasing among young individuals in the Arab world as well as in other regions of the world. Makhlouf NA et al tried to explore the incidence and prevalence of CRC in the Arab world, and found that there is a considerable prevalence of CRC in some Arab countries. It is very useful for the specialists in this area." 
Makhlouf NA, Abdel-Gawad M, Mahros AM, Lashen SA, Zaghloul M, Eliwa A, Elshemy EE, Ali-Eldin Z, Abdeltawab D, El-Raey F, Omran D, Khalaf M, Fanous N, Abdelmohsen AS, Abu-Elfatth A, Abdelghani M, Farouk M, Abdelaziz M, Alboraie M. Colorectal cancer in Arab world: A systematic review. World J Gastrointest Oncol 2021; 13(11): 1791-1798 [PMID: 34853651 DOI: 10.4251/wjgo.v13.i11.1791]
15
"Dietary zinc deficiency has been shown to be associated with the development of esophageal cancer in humans, but the exact mechanism of action is not known. Chen Y et al tried to observe the effects of dietary zinc deficiency on esophageal squamous cell proliferation, and showed that the ZD diet decreased the growth rate and promoted the proliferation of esophageal squamous cells in mice. This study will be useful for the clinicians of esophageal cancer." 
Chen Y, Liu FX, Liu H. Effects of dietary zinc deficiency on esophageal squamous cell proliferation and the mechanisms involved. World J Gastrointest Oncol 2021; 13(11): 1755-1765 [PMID: 34853648 DOI: 10.4251/wjgo.v13.i11.1755]
16
"Albumin-bound paclitaxel (ABP) has been used as second- and higher-line treatments for advanced esophageal cancer, and its efficacy and safety have been well demonstrated. Yan MH et al tried to investigate the efficacy and safety of induction chemotherapy with ABP plus LBP followed by concurrent radiochemotherapy (RCT) for locally advanced esophageal cancer. The data indicated that induction chemotherapy with ABP plus LBP followed by concurrent RCT is effective in patients with locally advanced ESCC, with mild adverse effects. This study will be useful for the clinicians of esophageal cancer." 
Yan MH, Liu F, Qu BL, Cai BN, Yu W, Dai XK. Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer. World J Gastrointest Oncol 2021; 13(11): 1781-1790 [PMID: 34853650 DOI: 10.4251/wjgo.v13.i11.1781]
17
"The role of transforming growth factor beta (TGF-β) signaling, including both the cytokine and their receptors, in the etiology of colorectal cancer (CRC) has been of particular interest lately. Stanilov N et al. tried to investigate the association between promoter polymorphism in TGF-β receptor 2 TGF-ΒR2G[-875]A with a CRC risk in a cohort of Bulgarian patients using a case-control gene association study approach. The results showed that TGF-ΒR2 AG and AA genotypes were associated with a reduced risk of CRC, as well as circulating levels of TGF-β could prevent CRC development in a gender-specific manner. It will be helpful for the clinicians in this area." 
Stanilov N, Grigorova A, Velikova T, Stanilova SA. Genetic variation of TGF-ΒR2 as a protective genotype for the development of colorectal cancer in men. World J Gastrointest Oncol 2021; 13(11): 1766-1780 [PMID: 34853649 DOI: 10.4251/wjgo.v13.i11.1766]
18
"Hepatocellular carcinoma (HCC) is characterized by dysregulation of the immune microenvironment and the development of chemoresistance. This study by Deng Z et al investigated the efficacy of SYPs for HCC treatment via simultaneous HIF-1α and PD-L1 inhibition and the mechanism involved. The data showed that SYPs inhibit immune escape and enhance chemosensitization in HCC via simultaneous inhibition of HIF-1α and PD-L1, thus inhibiting the growth of subcutaneous xenograft HCC tumours. It is very interesting." 
Deng Z, Teng YJ, Zhou Q, Ouyang ZG, Hu YX, Long HP, Hu MJ, Mei S, Lin FX, Dai XJ, Zhang BY, Feng T, Tian XF. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(11): 1725-1740 [PMID: 34853646 DOI: 10.4251/wjgo.v13.i11.1725]
19
"The authors demonstrated that hypoxia-inducible factor-1a induced chromobox (CBX)8 transcription by binding to the promoter of CBX8. CBX8 efficiently activated the PI3K/AKT signaling by upregulating insulin receptor substrate 1. Teng BW et al investigated the function of the chromobox 8 (CBX8)/receptor substrate 1 (IRS1)/AKT axis in PC, and found that CBX8 is a key gene regulated by HIF-1α, and activates the IRS1/AKT pathway, which suggests that targeting CBX8 may be a promising therapeutic strategy for PC. It is very useful for the specialists in this area." 
Teng BW, Zhang KD, Yang YH, Guo ZY, Chen WW, Qiu ZJ. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. World J Gastrointest Oncol 2021; 13(11): 1709-1724 [PMID: 34853645 DOI: 10.4251/wjgo.v13.i11.1709]
20
"Cancer of the biliary confluence also known as hilar cholangiocarcinoma (HC) or Klatskin tumor, is a rare type of neoplastic disease constituting approximately 40%-60% of intrahepatic malignancies, and 2% of all cancers. The study tried to review currently available treatment options for unresectable HC and discusses future perspectives that could optimize outcomes. It is very useful." 
Inchingolo R, Acquafredda F, Ferraro V, Laera L, Surico G, Surgo A, Fiorentino A, Marini S, de'Angelis N, Memeo R, Spiliopoulos S. Non-surgical treatment of hilar cholangiocarcinoma. World J Gastrointest Oncol 2021; 13(11): 1696-1708 [PMID: 34853644 DOI: 10.4251/wjgo.v13.i11.1696]
21
"Pancreatic cancer is a highly lethal malignancy with low resection and survival rates and is not sensitive to radiotherapy and chemotherapy. Yang Y et al tried to summarize the mechanism, inducers, and developments of ferroptosis in pancreatic cancer. It is very useful for the specialists in this area." 
Yang Y, Zhang ZJ, Wen Y, Xiong L, Huang YP, Wang YX, Liu K. Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway. World J Gastrointest Oncol 2021; 13(11): 1668-1679 [PMID: 34853642 DOI: 10.4251/wjgo.v13.i11.1668]
22
"For the last decade, the interest in extracellular vesicles (EVs) research has exponentially increased as EVs generation appears to be a universal feature of every cell that is strongly involved in many mechanisms of cell-cell communication either in physiological or pathological situations. Mammes A et al tried to review the role of EVs production in colorectal normal and cancer tissues. Specific attention is paid to the use of EVs for early CRC diagnosis, follow-up, and prognosis as EVs have come into the spotlight of research as a high potential source of ‘liquid biopsies’. This study will be useful for the clinicians." 
Mammes A, Pasquier J, Mammes O, Conti M, Douard R, Loric S. Extracellular vesicles: General features and usefulness in diagnosis and therapeutic management of colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1561-1598 [PMID: 34853637 DOI: 10.4251/wjgo.v13.i11.1561]
23
"Gastrointestinal (GI) cancer, including esophageal, gastric, and colorectal cancer, is one of the most prevalent types of malignant carcinoma and the leading cause of cancer-related deaths. Lv X et al tried to present the most recent literature on the current understanding of the roles played by the TGF-β signaling pathway in resistance to conventional chemotherapy, targeted therapy, immunotherapy, and traditional medicine in GI cancers as well as the various processes by which this occurs, including epithelial-mesenchymal transition, cancer stem cell development, tumor microenvironment alteration, and microRNA biogenesis. This study will be useful for the clinicians of GI." 
Lv X, Xu G. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers. World J Gastrointest Oncol 2021; 13(11): 1648-1667 [PMID: 34853641 DOI: 10.4251/wjgo.v13.i11.1648]
24
"The mammalian target of rapamycin (mTOR) acts in two structurally and functionally distinct protein complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Joechle K et al. tried to provide an update of the latest advances in knowledge on the role of mTORC2/Rictor in cancer, with special focus on primary liver cancer but also on liver metastases. It will be helpful for the clinicians in this area." 
Joechle K, Guenzle J, Hellerbrand C, Strnad P, Cramer T, Neumann UP, Lang SA. Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer. World J Gastrointest Oncol 2021; 13(11): 1632-1647 [PMID: 34853640 DOI: 10.4251/wjgo.v13.i11.1632]
25
"Hepatocellular carcinoma (HCC) is the most common cancer and the second major contributor to cancer-related mortality. This study attempted to review the radiomics approach and its current state-of-the-art clinical application scenario in HCC. It is very interesting." 
Yao S, Ye Z, Wei Y, Jiang HY, Song B. Radiomics in hepatocellular carcinoma: A state-of-the-art review. World J Gastrointest Oncol 2021; 13(11): 1599-1615 [PMID: 34853638 DOI: 10.4251/wjgo.v13.i11.1599]
26
"Liver cancer is a leading cause of death worldwide, and hepatocellular carcinoma (HCC) is the most frequent primary liver tumour, followed by cholangiocarcinoma. This review summarized the current knowledge regarding the potential role of the microbiota and immune system in primary and secondary liver cancer development, focusing on the potential therapeutic implications. It is very useful for the specialists in this area." 
Bartolini I, Risaliti M, Tucci R, Muiesan P, Ringressi MN, Taddei A, Amedei A. Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment. World J Gastrointest Oncol 2021; 13(11): 1616-1631 [PMID: 34853639 DOI: 10.4251/wjgo.v13.i11.1616]
27
"Colorectal cancer (CRC) represents one of the most frequent malignancies in terms of incidence and mortality, thus representing the third leading cause of cancer death worldwide. The study by Cherri S et al discussed The main limitations of targeted therapy in the treatment of metastatic CRC (mCRC), new target armamentarium that could escape primary and secondary resistance and lead to more personalized mCRC therapy. It is very useful." 
Cherri S, Libertini M, Zaniboni A. New drugs for the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1551-1560 [PMID: 34853636 DOI: 10.4251/wjgo.v13.i11.1551]
28
"This editorial by Jeong KY et al tried to introduce the progress in ADP-Ribose. Inhibition of poly (ADP-Ribose) polymerase-1 has emerged as a promising therapeutic target for BRCAness pancreatic cancer within the framework of an increase in genome instability. It is very interesting." 
Jeong KY, Lee H. Inhibition of poly (ADP-Ribose) polymerase: A promising strategy targeting pancreatic cancer with BRCAness phenotype. World J Gastrointest Oncol 2021; 13(11): 1544-1550 [PMID: 34853635 DOI: 10.4251/wjgo.v13.i11.1544]
29
"I read the study carefully. I think it is a good work in the field." 
Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [DOI: 10.5500/wjt.v11.i11.480]
30
"Thank you for this presentation" 
Dashti-Khavidaki S, Saidi R, Lu H. Current status of glucocorticoid usage in solid organ transplantation. World J Transplant 2021; 11(11): 443-465 [DOI: 10.5500/wjt.v11.i11.443]
31
"This is a very interesting study showing favorable results in the treatment of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis strains in pulmonary infections. Faster reduction of symptoms and faster recovery of patients using a combination of teicoplanin and vancomycin was confirmed. What is a basic indicator of the success of hospital treatment, and could significantly improve this study is the fact whether this antibiotic combination shortened the length of hospitalization in these patients. It would be expected that a combination of drugs could shorten the length of hospitalization, and possibly the length of antibiotic treatment. A data that could also significantly contribute to the possible use of both drugs in clinical use is an effect of this antibiotic combination on survival. With this information, the need for a combination of drugs would be clearer. If these outcomes are not changed, the use of a combination of drugs may develop greater resistance." 
Wu W, Liu M, Geng JJ, Wang M. Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections. World J Clin Cases 2021; 9(34): 10549-10556 [DOI: 10.12998/wjcc.v9.i34.10549]
32
"Very well written article." 
Mao SH, Feng DD, Wang X, Zhi YH, Lei S, Xing X, Jiang RL, Wu JN. Magnolol protects against acute gastrointestinal injury in sepsis by down-regulating regulated on activation, normal T-cell expressed and secreted. World J Clin Cases 2021; 9(34): 10451-10463 [DOI: 10.12998/wjcc.v9.i34.10451]
33
"Very well written article." 
Li SY, Wang Y, Wang LH. Chronic lymphocytic leukemia/small lymphocytic lymphoma complicated with skin Langerhans cell sarcoma: A case report . World J Clin Cases 2021; 9(34): 10715-10722 [DOI: 10.12998/wjcc.v9.i34.10715]
34
"Very well written article." 
Peng XH, Zhang LS, Li LJ, Guo XJ, Liu Y. Aggressive natural killer cell leukemia with skin manifestation associated with hemophagocytic lymphohistiocytosis: A case report. World J Clin Cases 2021; 9(34): 10708-10714 [DOI: 10.12998/wjcc.v9.i34.10708]
35
"Interesting data." 
Koh JS, Kim YJ, Kang DH, Lee JE, Lee SI. Severe mediastinitis and pericarditis after endobronchial ultrasound-guided transbronchial needle aspiration: A case report. World J Clin Cases 2021; 9(34): 10723-10727 [DOI: 10.12998/wjcc.v9.i34.10723]
36
"Interesting data." 
Jiang XD, Guo S, Zhang WM. Acute myocardial infarction induced by eosinophilic granulomatosis with polyangiitis: A case report. World J Clin Cases 2021; 9(34): 10702-10707 [DOI: 10.12998/wjcc.v9.i34.10702]
37
"Interesting data." 
Kim JY, Chang MC. Obturator hernia - a rare etiology of lateral thigh pain: A case report. World J Clin Cases 2021; 9(34): 10728-10732 [DOI: 10.12998/wjcc.v9.i34.10728]
38
"Interesting data." 
Han CY, Wang DZ, Bai JF, Zhao LL, Song WZ. Peri-implant keratinized gingiva augmentation using xenogeneic collagen matrix and platelet-rich fibrin: A case report. World J Clin Cases 2021; 9(34): 10738-10745 [DOI: 10.12998/wjcc.v9.i34.10738]
39
"Very well written article." 
Li KX, Luo YT, Zhou L, Huang JP, Liang P. Tracheal tube misplacement in the thoracic cavity: A case report. World J Clin Cases 2021; 9(34): 10733-10737 [DOI: 10.12998/wjcc.v9.i34.10733]
40
"Very well written article." 
Lin IH, Tsai CH. Tigecycline sclerotherapy for recurrent pseudotumor in aseptic lymphocyte-dominant vasculitis-associated lesion after metal-on-metal total hip arthroplasty: A case report. World J Clin Cases 2021; 9(34): 10696-10701 [DOI: 10.12998/wjcc.v9.i34.10696]
41
"Very well written article." 
Zhang L, Guan WK, Wu HP, Li X, Lv KP, Zeng CL, Song HH, Ye QL. Proximal true lumen collapse in a chronic type B aortic dissection patient: A case report. World J Clin Cases 2021; 9(34): 10689-10695 [DOI: 10.12998/wjcc.v9.i34.10689]
42
"Very well written article." 
Chen ZX, Shi Z, Wang B, Zhang Y. Intracuff alkalinized lidocaine to prevent postoperative airway complications: A meta-analysis. World J Clin Cases 2021; 9(34): 10626-10637 [DOI: 10.12998/wjcc.v9.i34.10626]
43
"Very well written article." 
Ju Q, Wu YT, Zhang Y, Yang WH, Zhao CL, Zhang J. Histology transformation-mediated pathological atypism in small-cell lung cancer within the presence of chemotherapy: A case report. World J Clin Cases 2021; 9(34): 10652-10658 [DOI: 10.12998/wjcc.v9.i34.10652]
44
"Very well written article." 
Wang C, Dou LW, Wang TB, Guo Y. Reversible congestive heart failure associated with hypocalcemia: A case report. World J Clin Cases 2021; 9(34): 10659-10665 [DOI: 10.12998/wjcc.v9.i34.10659]
45
"Very well written article." 
Hou FJ, Ma XT, Zhou YJ, Guan J. Excimer laser coronary atherectomy for a severe calcified coronary ostium lesion: A case report. World J Clin Cases 2021; 9(34): 10666-10670 [DOI: 10.12998/wjcc.v9.i34.10666]
46
"Interesting paper." 
Xu YW, Wang JQ, Zhang W, Xu SC, Li YX. Rarely fast progressive memory loss diagnosed as Creutzfeldt-Jakob disease: A case report. World J Clin Cases 2021; 9(34): 10638-10644 [DOI: 10.12998/wjcc.v9.i34.10638]
47
"Interesting paper." 
Gu HL, Zheng XQ, Zhan SQ, Chang YB. Intravascular papillary endothelial hyperplasia as a rare cause of cervicothoracic spinal cord compression: A case report. World J Clin Cases 2021; 9(34): 10681-10688 [DOI: 10.12998/wjcc.v9.i34.10681]
48
"Interesting paper." 
Kaur H, Mohanty S, Kochhar GK, Iqbal S, Verma A, Bhasin R, Kochhar AS. Comprehensive management of malocclusion in maxillary fibrous dysplasia: A case report. World J Clin Cases 2021; 9(34): 10671-10680 [DOI: 10.12998/wjcc.v9.i34.10671]
49
"Interesting paper." 
Moura DTH, McCarty TR, Jirapinyo P, Ribeiro IB, Farias GFA, Madruga-Neto AC, Ryou M, Thompson CC. Endoscopic ultrasound fine needle aspiration vs fine needle biopsy in solid lesions: A multi-center analysis. World J Clin Cases 2021; 9(34): 10507-10517 [DOI: 10.12998/wjcc.v9.i34.10507]
50
"Interesting paper." 
Wang XK, Zhou MH. Clinical features and survival of patients with multiple primary malignancies. World J Clin Cases 2021; 9(34): 10484-10493 [DOI: 10.12998/wjcc.v9.i34.10484]